Concepedia

Pavel A. Nikitin

PA

Statistics

Publications

13

Citations

977

H-Index

11

Active since

2003

Affiliations

Duke University(Current)

Immunome (United States)

Novartis (United States)

Harvard University

Imperial College London

Pavel A. Nikitin is an author at Duke University specializing in life sciences, molecular virology, and b cell biology.

ORCID

Publications per year

2003–2023

13

Publications

13

An ATM/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells

Pavel A. Nikitin, Christopher M. Yan, Eleonora Forte et al. · Cell Host & Microbe · 2010 · 245 citations · Full text

, , +17

Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes

Claudio Ciferri, Sumana Chandramouli, Danilo Donnarumma et al. · Proceedings of the National Academy of Sciences · 2015 · 158 citations · Full text

, , +15

Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody

Sumana Chandramouli, Claudio Ciferri, Pavel A. Nikitin et al. · Nature Communications · 2015 · 137 citations · Full text

, , +17

Metabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization

Karyn McFadden, Amy Y. Hafez, Rigel J. Kishton et al. · Proceedings of the National Academy of Sciences · 2016 · 127 citations · Full text

, , +17

Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection

Alexander M. Price, Joanne Dai, Quentin Bazot et al. · eLife · 2017 · 79 citations · Full text

, , +16

1–5 of 13